Literature DB >> 16906404

Continuous gluconic acid production by the yeast-like Aureobasidium pullulans in a cascading operation of two bioreactors.

Savas Anastassiadis1, Hans-Jürgen Rehm.   

Abstract

The application of a new developed process for the continuous production of gluconic acid using a cascade of two bioreactors in a continuous process is shown reaching the highest concentration of gluconic acid described in the literature for continuous culture fermentation. Very high gluconic acid concentrations of 272-308 g/l have been achieved under continuous cultivation of free-growing cells of Aureobasidium pullulans in the first bioreactor at residence times (RT) between 19.5 and 24 h with formation rates for the generic product between 12.7 and 13.9 g/(l h). Gluconic acid, 350-370 g/l, was continuously reached in the second bioreactor at a total RT of 30.8-37 h with R (j) of 9.2-12 g/(l h). The highest specific gluconic acid production (m (p)) of 3.6 g/(g h) was found in the first bioreactor at the lowest RT of 19.5 h. The highest selectivity of 93.6% was determined in the first bioreactor as well. Complete glucose consumption was obtained at 37 h total residence time in the second bioreactor. Gluconic acid, 433 g/l, was continuously produced in the second bioreactor at a total RT of 37 h.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16906404     DOI: 10.1007/s00253-006-0499-y

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  2 in total

Review 1.  Production of Gluconic Acid and Its Derivatives by Microbial Fermentation: Process Improvement Based on Integrated Routes.

Authors:  Yan Ma; Bing Li; Xinyue Zhang; Chao Wang; Wei Chen
Journal:  Front Bioeng Biotechnol       Date:  2022-05-16

2.  Characterization of newly isolated oleaginous yeasts - Cryptococcus podzolicus, Trichosporon porosum and Pichia segobiensis.

Authors:  Ines Schulze; Silla Hansen; Steffen Großhans; Thomas Rudszuck; Katrin Ochsenreither; Christoph Syldatk; Anke Neumann
Journal:  AMB Express       Date:  2014-03-18       Impact factor: 3.298

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.